Sensory nerve release of CGRP increases tumor growth in HNSCC by suppressing TILs
Laurel B. Darragh, Alexander Nguyen, Tiffany Pham, Shaquia Idlett-Ali, Michael W. Knitz, Jacob Gadwa, Sanjana Bukkapatnam, Sophia Corbo, Nicholas A. Olimpo, Diemmy Nguyen, Benjamin Van Court, Brooke Neupert, Justin Yu, Richard B. Ross, Michaele Francesco Corbisiero, Khalid N.M. Abdelazeem, Sean P. Maroney, David Ceja-Galindo, Laith Mukdad, Anthony J. Saviola, Molishree Joshi, Ruth A. White, Yazeed Alhiyari, Von G. Samedi, Adrie van Bokhoven, Maie A. St. John, Sana D. Karam
Abstract
BACKGROUND: Perineural invasion (PNI) and nerve density within the tumor microenvironment (TME) have long been associated with worse outcomes in head and neck squamous cell carcinoma (HNSCC). This prompted an investigation into how nerves within the tumor microenvironment affect the adaptive immune system and tumor growth. METHODS: We used RNA sequencing analysis of human tumor tissue from a recent HNSCC clinical trial, proteomics of human nerves from HNSCC patients, and syngeneic orthotopic murine models of HPV-unrelated HNSCC to investigate how sensory nerves modulate the adaptive immune system. FINDINGS: Calcitonin gene-related peptide (CGRP) directly inhibited CD8 T cell activity in vitro, and blocking sensory nerve function surgically, pharmacologically, or genetically increased CD8 and CD4 T cell activity in vivo. CONCLUSIONS: Our data support sensory nerves playing a role in accelerating tumor growth by directly acting on the adaptive immune system to decrease Th1 CD4 T cells and activated CD8 T cells in the TME. These data support further investigation into the role of sensory nerves in the TME of HNSCC and points toward the possible treatment efficacy of blocking sensory nerve function or specifically inhibiting CGRP release or activity within the TME to improve outcomes. FUNDING: 1R01DE028282-01, 1R01DE028529-01, 1P50CA261605-01 (to S.D.K.), 1R01CA284651-01 (to S.D.K.), and F31 DE029997 (to L.B.D.).